OUR STORY
We didn't set out to be a skin care company
OUR STORY
We didn't set out to be a skin care company
As scientists with PhDs in skin regeneration, stem cell biology, immunology, and bioinformatics, our journey began with a simple question: are any of the so-called anti-aging products on the market actually effective? To our surprise, most didn’t promote real rejuvenation. And evaluating them in the lab, we discovered some were even harmful at the cellular level.That’s when we rolled up our sleeves and got to work. More than 5 years of research and 900+ peptides later, we developed OS-01 – the first ingredient scientifically proven to reverse skin’s biological age. By targeting cellular senescence (one of the key drivers of skin aging) OS-01 switches off the damaged cells that contribute to lines, wrinkles, and sagging skin.But our vision was never just about looks. We started OneSkin to enhance how skin functions, so it stays healthier and more resilient as you age. Think of it as a long-term fitness plan for your skin. As your body’s largest organ, it’s crucial to make skin health a part of your overall approach to longevity — one that we believe also includes nutrient-dense foods, consistent exercise, stress management, and mental and emotional health.Good health is about feeling unstoppable, inside and out. That’s what drives us. And through our rigorous R&D process, peer-reviewed data, passion for life, and insatiable curiosity, we’re redefining the expectations around aging, empowering you with the knowledge to decide for yourself and enjoy life without limits.
As scientists with PhDs in skin regeneration, stem cell biology, immunology, and bioinformatics, our journey began with a simple question: are any of the so-called anti-aging products on the market actually effective? To our surprise, most didn’t promote real rejuvenation. And evaluating them in the lab, we discovered some were even harmful at the cellular level.That’s when we rolled up our sleeves and got to work. More than 5 years of research and 900+ peptides later, we developed OS-01 – the first ingredient scientifically proven to reverse skin’s biological age. By targeting cellular senescence (one of the key drivers of skin aging) OS-01 switches off the damaged cells that contribute to lines, wrinkles, and sagging skin.But our vision was never just about looks. We started OneSkin to enhance how skin functions, so it stays healthier and more resilient as you age. Think of it as a long-term fitness plan for your skin. As your body’s largest organ, it’s crucial to make skin health a part of your overall approach to longevity — one that we believe also includes nutrient-dense foods, consistent exercise, stress management, and mental and emotional health.Good health is about feeling unstoppable, inside and out. That’s what drives us. And through our rigorous R&D process, peer-reviewed data, passion for life, and insatiable curiosity, we’re redefining the expectations around aging, empowering you with the knowledge to decide for yourself and enjoy life without limits.
Our leadership team
Our leadership team is composed of four scientists united in their passion to develop solutions to prolong human healthspan.
01
Carolina Reis Oliveira, PhD
Co-Founder and Chief Executive Officer
Co-Founder and Chief Executive Officer
Carolina holds her Ph.D. in Immunology at the Federal University of Minas Gerais in collaboration with Rutgers University and is an alumnus of IndieBio, the world's leading biotechnology accelerator. In 2016, Carolina relocated to Silicon Valley from Latin America to co-found OneSkin, and to lead the development of the company’s disruptive rejuvenation technologies.
Our leadership team
Our leadership team is composed of four scientists united in their passion to develop solutions to prolong human healthspan.
01
Carolina Reis Oliveira, PhD
Co-Founder and Chief Executive Officer
Co-Founder and Chief Executive Officer
Carolina holds her Ph.D. in Immunology at the Federal University of Minas Gerais in collaboration with Rutgers University and is an alumnus of IndieBio, the world's leading biotechnology accelerator. In 2016, Carolina relocated to Silicon Valley from Latin America to co-found OneSkin, and to lead the development of the company’s disruptive rejuvenation technologies.
02
Alessandra Zonari, PhD
Co-Founder and Chief Scientific Officer
Co-Founder and Chief Scientific Officer
Alessandra Zonari, PhD, co-founder and Chief Scientific Officer, earned her Master’s degree in stem cell biology, and her PhD in skin regeneration and tissue engineering at the Federal University of Minas Gerais in Brazil in collaboration with the 3B’s Research Group in Portugal. Alessandra did a second post-doctoral at the University of Coimbra in Portugal. She is a co-inventor of three patents and has published 20 peer-reviewed papers in scientific journals.
02
Alessandra Zonari, PhD
Co-Founder and Chief Scientific Officer
Co-Founder and Chief Scientific Officer
Alessandra Zonari, PhD, co-founder and Chief Scientific Officer, earned her Master’s degree in stem cell biology, and her PhD in skin regeneration and tissue engineering at the Federal University of Minas Gerais in Brazil in collaboration with the 3B’s Research Group in Portugal. Alessandra did a second post-doctoral at the University of Coimbra in Portugal. She is a co-inventor of three patents and has published 20 peer-reviewed papers in scientific journals.
03
Mariana Boroni, PhD
Co-Founder
Co-Founder
Mariana Boroni, PhD, co-founder and Head of Bioinformatics, earned her Master’s degree in biochemistry, and her PhD in bioinformatics with an emphasis in genomics at the Federal University of Minas Gerais. Mariana did her post-doctoral at the Ludwig-Maximilians University of Munich in Germany, and worked as a visiting researcher at the University of Birmingham, England. Mariana is Head of the Bioinformatics and Computational Biology Lab at the Brazilian National Cancer Institute (INCA). She shares her time between leading research at INCA and leading bioinformatics at Oneskin. Together with the OneSkin team, Mariana developed the company’s proprietary skin-specific DNAm age predictor. Mariana is co-inventor of four patents, and has published more than 20 peer-reviewed papers in scientific journals.
03
Mariana Boroni, PhD
Co-Founder
Co-Founder
Mariana Boroni, PhD, co-founder and Head of Bioinformatics, earned her Master’s degree in biochemistry, and her PhD in bioinformatics with an emphasis in genomics at the Federal University of Minas Gerais. Mariana did her post-doctoral at the Ludwig-Maximilians University of Munich in Germany, and worked as a visiting researcher at the University of Birmingham, England. Mariana is Head of the Bioinformatics and Computational Biology Lab at the Brazilian National Cancer Institute (INCA). She shares her time between leading research at INCA and leading bioinformatics at Oneskin. Together with the OneSkin team, Mariana developed the company’s proprietary skin-specific DNAm age predictor. Mariana is co-inventor of four patents, and has published more than 20 peer-reviewed papers in scientific journals.
04
Juliana Carvalho, PhD
Co-Founder
Co-Founder
Juliana Carvalho, PhD, earned her Master’s degree in biochemistry and immunology, and her PhD in molecular biology from the Federal University of Minas Gerais in Brazil. In 2015, Juliana joined the Catholic University of Brasilia as a professor of pathology, and in 2019, she joined the Faculty of Medicine at the University of Brasilia. As an advisor to students earning their Masters and PhD degrees in science at both the University of Brasilia and the Catholic University of Brasilia, Juliana guides the newest scientists of our generation. Juliana is co-inventor of four patents, and has published 34 peer-reviewed papers in scientific journals (and counting!).
04
Juliana Carvalho, PhD
Co-Founder
Co-Founder
Juliana Carvalho, PhD, earned her Master’s degree in biochemistry and immunology, and her PhD in molecular biology from the Federal University of Minas Gerais in Brazil. In 2015, Juliana joined the Catholic University of Brasilia as a professor of pathology, and in 2019, she joined the Faculty of Medicine at the University of Brasilia. As an advisor to students earning their Masters and PhD degrees in science at both the University of Brasilia and the Catholic University of Brasilia, Juliana guides the newest scientists of our generation. Juliana is co-inventor of four patents, and has published 34 peer-reviewed papers in scientific journals (and counting!).